Semaglutide
-
healthNew Protein Discovery Offers Hope for Reversing Osteoarthritis
Researchers identify a key protein linked to aging joints, paving the way for potential new osteoarthritis treatments that could regenerate cartilage and restore mobility.
-
healthOral Semaglutide Shows Efficacy in Pediatric Type 2 Diabetes Trial
Phase 3 PIONEER TEENS trial demonstrates oral semaglutide's potential as a first-in-class treatment for adolescents with type 2 diabetes.
-
healthKetogenic Diet Dramatically Slashes Liver Fat in MASLD Patients
A very low-energy ketogenic diet significantly reduced liver fat by 77% in MASLD patients, far surpassing a Mediterranean diet in a pilot study.
-
healthTirzepatide Linked to Greater Lean Mass Loss Than Semaglutide in New Analysis
Real-world study reveals tirzepatide patients may lose more lean body mass compared to semaglutide users, impacting metabolic health and aging.
-
healthNovo Nordisk Teams Up with OpenAI to Revolutionize Drug Development
Novo Nordisk announces a groundbreaking partnership with OpenAI, leveraging AI to accelerate drug discovery, streamline operations, and enhance patient care.
-
healthNovo Nordisk Unveils Higher-Dose Semaglutide for Weight Loss
Novo Nordisk introduces a new 7.2 mg semaglutide injection, offering adults an enhanced therapeutic option for weight management and potential for greater loss.
-
healthGLP-1 Drugs Show Safety, Better Outcomes in Pancreatitis Cases
Real-world data from 740,000+ Type 2 diabetes patients shows GLP-1 receptor agonists don't increase pancreatitis risk and reduce complications.
-
healthNHS to Offer Semaglutide to 1.2 Million Cardiovascular Patients
NICE approves Wegovy for high-risk patients following major clinical trials showing 20% reduction in cardiovascular events.